HomeREGULATORY
REGULATORY

Streamlining Regulations of Pharmaceutical Affairs to Be “a Top Priority” in 2018: MHLW Pharma Bureau Chief
(Jan.12.2018)

Shinji Miyamoto, Director General, Pharmaceutical Safety and Environmental Health Bureau
The Ministry of Health, Labor and Welfare’s (MHLW) Pharmaceutical Safety and Environmental Health Bureau will focus on “reducing costs and improving efficiency through regulatory reform,” one of the measures set forth in the plan to strengthen Japan’s ability to discover new drugs announced by the government at the end of last year, said the bureau’s Director General Shinji Miyamoto ...
(LOG IN FOR FULL STORY)

News Calendar